Search - tctmd.com

Displaying 701 - 720 of 720

Sort: Relevancy | Date

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

April 04, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

April 04, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

April 04, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

News Daily News

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

March 16, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

News Daily News

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

February 23, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

February 03, 2011

News Daily News

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

January 24, 2011

News Daily News

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

January 23, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

January 02, 2011

Presentation

Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD

Presenter: Jens Wiebe

February 16, 0017

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

CME

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

Latest Data on Left Main Stenting and its Implications

CME

Latest Data on Left Main Stenting and its Implications

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.